Dr Miles Parkes, Cambridge Dr Hannah Gordon, London RSM and CCUK® 2015 Who gets IBD and Why? Dr Miles Parkes, Cambridge Dr Hannah Gordon, London RSM and CCUK® 2015
Introduction Who? Why? Epidemiology Heritability – twin and family studies Genetics Environment Interface between Genes and Environment Microbiota Epigenetics
Prevalence UK prevalence 4/1000 620,000 affected within the UK (IBD Standards, CCUK® 2015)
Age All ages affected Peak incidence 15-30 years 2nd peak 50-80 years Incidence rising in children (Henderson 2012)
Sex Men and women are affected almost equally
Race Traditionally a disease of the West, rates of IBD remain high in Western Europe and North America (Cosnes 2011). However all countries are affected with incidence rapidly rising in Asia.
Highest incidence of IBD in the World Faroe Islands – 80 per 100,000 new cases diagnosed per year
Ethnicity and affluence Ashkenazi Jews Caucasians Socio-economic status Previously thought to be associated with affluence Not replicated in all studies
Is Inflammatory Bowel Disease Heritable? Heritability is the extent to which a trait is caused by our genes How can we estimate heritability of IBD? Family studies Twin studies Calculating extent identified genes explain IBD prevalence
Family studies The greatest single risk factor for developing IBD is having one or more first degree family members diagnosed Odds Ratio sibling risk vs population risk: CD 25-42 UC 4-15 However, family history only reported in 5-16% IBD patients
Family studies IBD in families shows concordance in Behaviour Location Age of onset IBD in families tends to present earlier and be more severe BUT Families share similar environment as well as similar genes…..
Twin studies Why? Both identical and non-identical twins share similar environment Identical share genetic code, twice as genetically similar How? Concordance of identical and non-identical twin pairs are compared Difference between identical and non identical groups is crucial – ie almost all twin pairs share a history for chickenpox, but this is not inherited!
UK Twins with IBD: Pair concordance (UK IBD TAM 2014) Previous twin cohorts (Tysk et al 1988, Halfvarson 2007, Brant 2011) The second table shows the range of concordance rates from previous twin studies. European cohorts similar sample sizes. Dizygotic concordance rates are higher than previous cohorts and indeed outweighing that expected by non twin siblings by over 4 fold. Crohn’s Disease Ulcerative Colitis Monozygotic 20-55% 3.6-17% Dizygotic 0-3.6% 0-6.3%
Compare the genomes of people with IBD vs people without IBD Genetic Studies Compare the genomes of people with IBD vs people without IBD => identify gene variants associated with IBD => work out functional impact + how they predispose to IBD (role for IBD Bioresource) => 1. clues re environmental triggers 2. ? ‘druggable’ targets
Genome Wide Association Scanning => Unbiased survey of whole genome Genotype >0.5 million markers in thousands of cases + controls Use stringent statistics to identify ‘associated’ SNPs i.e. with significantly different allele frequencies in cases vs controls Identify genes mapping to same region Study impact of associated gene variant on protein function in relevant cell type
UKIBDGC and IIBDGC GWAS Studies GWAS studies in IBD
GWAS meta-analysis + Immunochip deep replication Jostins et al Nature 2012: International IBD Genetics Consortium GWAS meta-analysis + Immunochip deep replication 163 discrete risk loci identified Immunchip - 14,763 CD / 10,920 UC / 15,977 control subjects GWAS - 6,333 CD / 6,687 UC / 15,056 control subjects
163 genes and loci: What have we learned? Large overlap between UC and CD Jostins et al. Nature 2012
Franke et al Nature Genet 2010. IL23R pathway Duerr et al Science 2006; Parkes et al Nature Genet 2007; Barrett et al Nature Genet 2008; Franke et al Nature Genet 2010. IFNgamma IL-17 IL-6 TNF alpha IL-12 p40 p35 IL-23 CCR6 p19 p40 Th 17 Th 1 STAT4 STAT3 Naive CD4+ve T Cell ICOSL JAK2 McKenzie et al. TRENDS in Immunology 2006:27(1), 17-23 ICOS
Clinical impact… A pipeline for drug discovery
Genes discovered ‘early’ have biggest effect: Odds ratio for CD according to NOD2 genotype NOD2 not assoc with UC
3 main mutations – all in LRR domain NOD2 domains & mutations CARD 1 2 NBD LRR * * § * non-synonymous § frameshift - premature stop 3 main mutations – all in LRR domain
Autophagy
ATG16L1 ATG16L1 – a key component of autophagy independent discovery in German, N American (NIDDK) and UK (WTCCC) CD GWA panels Hampe et al Nature Genetics 2007 Rioux et al Nature Genetics 2007 WTCCC Nature 2007
Association at IRGM – another autophagy gene Parkes et al. Nature Genetics 2007
The power of hypothesis-free GWAS 2 genes in same (previously unsuspected) pathway associated with CD susceptibility = ATG16L1 and IRGM
Autophagy lysosome AH AH Phagophore cytoplasm Autophagolysosome Autophagosome Autophagolysosome
T300A ↑↑ cleavage of ATG16L1 by caspase 3 when latter is activated through TNF / metabolic / infection stress ↓↓ xenophagy disrupted pathogen elimination Murthy et al Nature 2014
Epithelial barrier loci - HNF4a E-cadherin...etc GWAS studies in UC UC-specific Epithelial barrier loci - HNF4a E-cadherin...etc Franke et al Nat Genet 2009 Fisher et al Nat Genet 2008 Silverberg et al 2009 UKIBDGC / WTCCC Nat Genet 2009
Epithelial barrier Increased permeability as risk for IBD Allows commensals to breach epithelial barrier and activate mucosal immune system Questions: Why UC-specific? What leaks through?
Overlap with other diseases Fold enrichment Ankylosing spondylitis 13.7 Psoriasis 13.4 Atopic dermatitis 12.2 Primary sclerosing cholangitis 11.6 Primary biliary cirrhosis 10.8 Rheumatoid arthritis 10.1 Celiac disease Type 1 diabetes 9.9 Systemic lupus erythematosus Multiple sclerosis 8.1 Asthma 7.6 Jostins et al. Nature 2012 ... implicates Mycobacterial infection as a evolutionary selection pressure for IBD?
Rapid rise in IBD suggests environment is critical Genes Environment
Rise of IBD in the East 2-3 fold increase in IBD incidence in past 10-20 years in several Asian countries Mirrors increase seen in Western countries 50 years ago More UC, although CD rapidly increasing Only 3-10% report family history of IBD Far outweighs what can be explained by new genetic mutations
Migration studies Higher rates of IBD in Asians in Western Europe, Australia, Northern America Second generation Asian migrants in Leicestershire had UC rates comparable to Caucasian British Disease is as if not more severe, more likely to affect men, and less likely to affect outside the gut
Why the increase in Asia Diet Hygiene Infection Westernisation of lifestyle
Environmental factors Lifestyle Smoking Diet Low Exercise Stress Health Childhood illness Gastrointestinal infection Atypical Mycobacterium Appendicectomy Early Environment Emergency Caesarian Breastfeeding Medication Aspirin NSAIDS Oral Contraception Antibiotics
Diet Read made meals Polyunsaturated fats High sugar Low vegetable Low fruit Low fibre
Problems interpreting data on environmental factors Correlation not cause and effect Results vary between studies Each factor conveys a relatively modest risk Risk factors often not avoidable Important to avoid guilt or blame
The Microbiome 100 trillion bacteria within gut 10x more cells than human body Complex ecosystem Implicated in health of all other organs Cardiovascular disease Depression Obesity Inflammatory Bowel Disease
HMP Nature 2013 Significant variation between individuals re taxa / species BUT – key metabolic pathways are VERY stable in health
What influences composition of microbiota? Genetics Race Early environment Smoking Diet Antibiotics Infection Method of delivery The microbiota influence mucosal immune development and homeostasis – disturbance may contribute to development of IBD.
Dysbiosis in Crohn’s Disease – incl ↓ diversity Increased in CD Sokol et al PNAS 2009 Decreased in CD Gevers et al Cell Host and Microbe 2014
Is the bacterial dysbiosis secondary to bacteriophage ‘bloom’ Is the bacterial dysbiosis secondary to bacteriophage ‘bloom’? What functional elements are being transferred? What impact on host immunity? Norman et al. Cell 2015
The Microbiota and IBD Unclear whether changes happen before or after disease develops Cause or correlation?
Can we change the microbiota? Yes! Dietary change from vegan to exclusively meat and dairy changes microbiota substantially in days Some changes associated with meat diet were same as those associated with IBD Smoking cessation changes microbiota However Once IBD has developed, prebiotics, probiotics and faecal transplant not yet shown to be a cure
Epigenetics Epigenetics: programmed regulation of gene expression in response to environmental factors Epigenetic changes associated with CD and UC have been found in gut biopsies and blood Twin studies underway to further investigate
Conclusion: Anyone can get IBD Increased risks Genetic susceptibility Environmental triggers Dysbiosis of microbiota Epigenetic change Why important to understand? Prevention Prediction and early diagnosis Novel targets for treatment
The Jesse and Thomas TAM Family Foundation UK IBD Genetics Consortium